11 / 42
www.aoac.org
301.924.7077
11
U.S. PARTICIPATION IN CODEX ALIMENTARIUS, THE ROLE
OF STANDARD DEVELOPING ORGANIZATIONS
MONDAY, SEPTEMBER 19, 2016
|
10:30 AM – 12:00 PM
Greg Noonan, Ph.D., Director, Division of Bioanalytical Chemistry Food and
Drug Administration, U.S. Food and Drug Administration
‘Codex Alimentarius ’, or the “Food Code”, primary goal is to protect consumer
health by developing and implementing international standards, codes of practice,
and guidelines related to safe and high quality food. The U.S., led by the U.S. Codex
Office (USDA), engages with the 180 plus members of Codex Alimentarius through involvement with nearly 20 General
Subject and Commodity Committees. A critical part of the U.S. engagement relies on a variety of stakeholders, including
consumers, NGOs, industry and Standard Development Organizations (SDOs) such as AOAC INTERNATIONAL. While
safety can’t be tested into food, methods of analysis are a critical component to verifying that food meets both safety
and quality standards agreed to by international trading partners. AOAC INTERNATIONAL Official Methods are heavily
relied upon and have been “endorsed” by the Codex Committee on Methods of Analysis and Sampling (CCMAS) for
inclusion in numerous Codex Standards. However, the development of new commodity standards or new analytical
methods means that methods are often reviewed and updated. The acceptance of new methods into Codex Standards
requires careful planning, often with multiple Codex Committees, an understanding of Codex procedural rules and
patience. AOAC INTERNATIONAL’s continued engagement with U.S. Delegates to Codex Committees and yearly
participation in CCMAS is vital to ensuring newly developed methods are properly considered by Codex Committees.
About Dr. Noonan
Dr. Gregory Noonan joined the U.S. Food and Drug
Administration in 2002 and is currently the Director
of the Division of Bioanalytical Chemistry (DBC) in
the Office of Regulatory Science. The Division of
Bioanalytical Chemistry contains over 35 scientists
performing research and developing analytical
methods in numerous subject areas, including,
toxic elements analysis, immunodiagnostic and DNA-
based allergen detection, radionuclides, pesticide
analysis, mycotoxin analysis, dietary supplements
and botanicals, nutritional ingredients and cosmetics.
Prior to becoming Director, Dr. Noonan was a
Research Chemist in the Method Development
Branch of the Division of Analytical Chemistry.
His research focused on developing methods for the
determination of food additives, including indirect
additives, and process induced contaminants. Dr.
Noonan also serves as the U.S. Delegate to the Codex
Committee on Methods of Analysis and Sampling
(CCMAS), where he chairs the Working Group on the
Endorsement of Methods. Dr. Noonan received his
PhD in Chemistry from Michigan State University in
1996. After graduation he worked for the Diagnostic
Division of Abbott Laboratories, where he developed
diagnostic immunoassays for Hepatitis A, B and C
and HIV. After leaving Abbott Laboratories and prior
to joining the FDA, he was a postdoctoral fellow in
the Civil and Environmental Engineering department
of the Massachusetts Institute of Technology, where
he studied the fate and transport of polar, water
soluble environmental contaminants.
KEYNOTE
ADDRESS